Arctic Bioscience Balance Sheet Health
Financial Health criteria checks 4/6
Arctic Bioscience has a total shareholder equity of NOK235.1M and total debt of NOK0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are NOK273.2M and NOK38.1M respectively.
Key information
0%
Debt to equity ratio
NOK 0
Debt
| Interest coverage ratio | n/a |
| Cash | NOK 19.83m |
| Equity | NOK 235.09m |
| Total liabilities | NOK 38.12m |
| Total assets | NOK 273.21m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 9TD's short term assets (NOK74.8M) exceed its short term liabilities (NOK36.3M).
Long Term Liabilities: 9TD's short term assets (NOK74.8M) exceed its long term liabilities (NOK1.8M).
Debt to Equity History and Analysis
Debt Level: 9TD is debt free.
Reducing Debt: 9TD has no debt compared to 5 years ago when its debt to equity ratio was 22.5%.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 9TD has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: 9TD has less than a year of cash runway if free cash flow continues to reduce at historical rates of 10.1% each year